1,3-dihydro-2H-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9845321
SERIAL NO

14991815

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is concerned with novel 1,3-dihydro-2H-benzimidazol-2-one derivatives substituted with heterocycles having formula (I)

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JANSSEN SCIENCES IRELAND UCCO CORK

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cooymans, Ludwig Paul Beerse, BE 31 289
Demin, Samuel Dominique Antwerp, BE 8 16
Hu, Lili Mechelen, BE 55 504
Jonckers, Tim Hugo Maria Heist-op-den-Berg, BE 97 974
Raboisson, Pierre Jean-Marie Bernard Rosieres, BE 227 1880
Tahri, Abdellah Anderlecht, BE 78 535
Vendeville, Sandrine Marie Helene Woluwe-Saint-Pierre, BE 51 398

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 19, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 19, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00